106
Participants
Start Date
March 20, 2013
Primary Completion Date
February 6, 2017
Study Completion Date
February 6, 2017
Placebo
Placebo
Belimumab 10 mg/kg
Belimumab 10 mg/kg
Azathioprine
Azathioprine
GSK Investigational Site, Dublin
GSK Investigational Site, Dublin
GSK Investigational Site, Brussels
GSK Investigational Site, Budapest
GSK Investigational Site, West Springfield
GSK Investigational Site, Brussels
GSK Investigational Site, Liverpool
GSK Investigational Site, New Lambton
GSK Investigational Site, Garran
GSK Investigational Site, Leuven
GSK Investigational Site, Bern
GSK Investigational Site, Malvern
GSK Investigational Site, Debrecen
GSK Investigational Site, Kristiansand
GSK Investigational Site, México
GSK Investigational Site, Zurich
GSK Investigational Site, Barcelona
GSK Investigational Site, Sankt Gallen
GSK Investigational Site, New York
GSK Investigational Site, New York
GSK Investigational Site, Berlin
GSK Investigational Site, Great Neck
GSK Investigational Site, Prague
GSK Investigational Site, Prague
GSK Investigational Site, Prague
GSK Investigational Site, Stockholm
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Genoa
GSK Investigational Site, Philadelphia
GSK Investigational Site, Wyomissing
GSK Investigational Site, Milan
GSK Investigational Site, Madrid
GSK Investigational Site, Pessac
GSK Investigational Site, Rennes
GSK Investigational Site, Birmingham
GSK Investigational Site, Mobile
GSK Investigational Site, Bologna
GSK Investigational Site, Reggio Emilia
GSK Investigational Site, Columbus
GSK Investigational Site, Münster
GSK Investigational Site, Detroit
GSK Investigational Site, Milwaukee
GSK Investigational Site, Rochester
GSK Investigational Site, Lille
GSK Investigational Site, Torrette Di Ancona
GSK Investigational Site, Chicago
GSK Investigational Site, Kansas City
GSK Investigational Site, Bari
GSK Investigational Site, Stuttgart
GSK Investigational Site, Tübingen
GSK Investigational Site, Kirchheim unter Teck
GSK Investigational Site, Paris
GSK Investigational Site, München
GSK Investigational Site, Tucson
GSK Investigational Site, Covina
GSK Investigational Site, Palo Alto
GSK Investigational Site, San Leandro
GSK Investigational Site, Portland
GSK Investigational Site, Moscow
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Cluj-Napoca
GSK Investigational Site, Boston
GSK Investigational Site, Camden
GSK Investigational Site, Hamilton
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Montreal
GSK Investigational Site, Leipzig
GSK Investigational Site, Jena
GSK Investigational Site, Oslo
GSK Investigational Site, Callao
GSK Investigational Site, Lima
GSK Investigational Site, Lima
GSK Investigational Site, Lima
GSK Investigational Site, Lima
GSK Investigational Site, Lima
GSK Investigational Site, Lima
GSK Investigational Site, Gdansk
GSK Investigational Site, Katowice
GSK Investigational Site, Krakow
GSK Investigational Site, Lublin
GSK Investigational Site, Bucharest
GSK Investigational Site, Stavropol
GSK Investigational Site, Barcelona
GSK Investigational Site, Reading
GSK Investigational Site, Aberdeen
GSK Investigational Site, Cambridge
GSK Investigational Site, London
GSK Investigational Site, Oxford
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Human Genome Sciences Inc., a GSK Company
INDUSTRY